Antipsychotic Agents
"Antipsychotic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
Descriptor ID |
D014150
|
MeSH Number(s) |
D27.505.696.277.950.040 D27.505.954.427.210.950.040 D27.505.954.427.700.872.331
|
Concept/Terms |
Antipsychotic Agents- Antipsychotic Agents
- Agents, Antipsychotic
- Antipsychotics
- Major Tranquilizers
- Tranquilizers, Major
- Tranquillizing Agents, Major
- Agents, Major Tranquillizing
- Major Tranquillizing Agents
- Neuroleptic Drugs
- Drugs, Neuroleptic
- Neuroleptics
- Tranquilizing Agents, Major
- Agents, Major Tranquilizing
- Major Tranquilizing Agents
- Antipsychotic Drugs
- Drugs, Antipsychotic
- Neuroleptic Agents
- Agents, Neuroleptic
Antipsychotic Effect- Antipsychotic Effect
- Effect, Antipsychotic
- Antipsychotic Effects
- Effects, Antipsychotic
|
Below are MeSH descriptors whose meaning is more general than "Antipsychotic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antipsychotic Agents".
This graph shows the total number of publications written about "Antipsychotic Agents" by people in this website by year, and whether "Antipsychotic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 0 | 2 | 2 | 1981 | 0 | 1 | 1 | 1983 | 1 | 2 | 3 | 1985 | 0 | 1 | 1 | 1987 | 0 | 1 | 1 | 1988 | 1 | 0 | 1 | 1992 | 1 | 0 | 1 | 1994 | 1 | 0 | 1 | 1995 | 0 | 1 | 1 | 1996 | 2 | 1 | 3 | 1998 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2000 | 1 | 1 | 2 | 2001 | 1 | 0 | 1 | 2002 | 2 | 0 | 2 | 2003 | 4 | 2 | 6 | 2004 | 3 | 1 | 4 | 2005 | 2 | 3 | 5 | 2006 | 3 | 0 | 3 | 2007 | 0 | 1 | 1 | 2008 | 4 | 0 | 4 | 2009 | 1 | 2 | 3 | 2010 | 2 | 2 | 4 | 2011 | 1 | 0 | 1 | 2012 | 2 | 0 | 2 | 2013 | 0 | 1 | 1 | 2014 | 1 | 1 | 2 | 2015 | 1 | 0 | 1 | 2016 | 3 | 0 | 3 | 2017 | 1 | 2 | 3 | 2018 | 0 | 2 | 2 | 2019 | 4 | 0 | 4 | 2020 | 1 | 0 | 1 | 2021 | 1 | 0 | 1 | 2022 | 1 | 0 | 1 | 2023 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antipsychotic Agents" by people in Profiles.
-
Martino D, Karnik V, Bhidayasiri R, Hall DA, Hauser RA, Macerollo A, Pringsheim TM, Truong D, Factor SA, Skorvanek M, Schrag A. Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Mov Disord. 2023 06; 38(6):1008-1026.
-
Henry PH, Dantz B. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. JAMA. 2022 07 12; 328(2):213-214.
-
Karnik NS, Cortese S, Njoroge WFM, Drury SS, Frazier JA, McCauley E, Henderson SW, White T, Althoff RR, Novins DK. Editorial: Analyzing Treatment and Prescribing in Large Administrative Datasets With a Lens on Equity. J Am Acad Child Adolesc Psychiatry. 2021 07; 60(7):818-820.
-
Hauser RA, Meyer JM, Factor SA, Comella CL, Tanner CM, Xavier RM, Caroff SN, Lundt L. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice. CNS Spectr. 2022 04; 27(2):208-217.
-
Neft MW, Oerther S, Halloway S, Hanneman SK, Mitchell AM. Benzodiazepine and antipsychotic medication use in older adults. Nurs Open. 2020 01; 7(1):4-6.
-
Eckert EM, Dominick KC, Pedapati EV, Wink LK, Shaffer RC, Andrews H, Choo TH, Chen C, Kaufmann WE, Tartaglia N, Berry-Kravis EM, Erickson CA. Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis. J Autism Dev Disord. 2019 Nov; 49(11):4595-4602.
-
Marder SR, Singer C, Lindenmayer JP, Tanner CM, Comella CL, Verghese C, Jimenez R, Liang GS, Burke J, O'Brien CF. A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia. J Clin Psychopharmacol. 2019 Nov/Dec; 39(6):620-627.
-
Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL. Recent developments in drug-induced movement disorders: a mixed picture. Lancet Neurol. 2019 09; 18(9):880-890.
-
Aremu B, Hill PD, McNeal JM, Petersen MA, Swanberg D, Delaney KR. Implementation of Trauma-Informed Care and Brief Solution-Focused Therapy: A Quality Improvement Project Aimed at Increasing Engagement on an Inpatient Psychiatric Unit. J Psychosoc Nurs Ment Health Serv. 2018 Aug 01; 56(8):16-22.
-
Gottlieb M, Long B, Koyfman A. Approach to the Agitated Emergency Department Patient. J Emerg Med. 2018 04; 54(4):447-457.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|